Back to News
Market Impact: 0.35

Better AI Stock to Buy on the Dip: Micron or Microsoft?

MUMSFTNVDAINTCGOOGGOOGLNFLXNDAQ
Artificial IntelligenceTechnology & InnovationCompany FundamentalsCorporate EarningsCorporate Guidance & OutlookTrade Policy & Supply ChainAntitrust & CompetitionInvestor Sentiment & Positioning
Better AI Stock to Buy on the Dip: Micron or Microsoft?

Micron and Microsoft are presented as attractive AI-exposed investment opportunities for different horizons: Micron’s entire 2026 HBM supply is sold out amid strong DRAM/NAND demand, and management projects HBM TAM to grow from $35B in 2025 to $100B in 2028 (~40% CAGR), while the stock trades at about 12x forward earnings; shares are roughly 15% below a recent high. Microsoft’s multiple is near a 10-year low after Azure growth slightly missed expectations, plans for higher capex and slower-than-expected Copilot adoption, yet the company reports broad AI traction (over 80% of the Fortune 500 building agents with Microsoft tools) and is viewed as the better long-term winner despite a >20% decline since late October 2025.

Analysis

Market structure: AI-driven demand re-routes scarce HBM and DRAM capacity toward cloud/AI OEMs (NVDA, MSFT customers) and memory specialists (MU, Samsung). Expect pricing power for HBM to persist through 2026–2028 given Micron’s sold‑out 2026 HBM and projected TAM growth ~40% CAGR to $100B by 2028, pressuring end-market OEMs’ ASPs and margins if supply ramps lag demand. Risk assessment: Tail risks include abrupt demand softening from a macro slowdown or China export curbs (6–18 month shock), large-cap capex overbuild by foundries (12–24 months) and US/EU antitrust scrutiny on cloud/Ai bundling for MSFT (18+ months). Short-term (days–weeks) volatility will be driven by earnings surprises and capacity guidance; long-term (years) fundamentals hinge on secular AI adoption and supply expansion timelines. Trade implications: Near-term asymmetric trade — MU appears a high-gamma trade for 6–12 months (low 12x forward PE; core exposure 2–4% portfolio) while MSFT is a lower-volatility, long-duration growth hold to accumulate over 12–36 months. Use options to define risk: MU calendar/LEAP call spreads to capture upside while funding with covered-call sales; MSFT buy-and-hold with 12–24 month LEAP calls or short OTM puts to improve entry. Contrarian angles: Consensus underestimates the speed at which HBM scarcity can flip to oversupply once new nodes come online — inventory-led DRAM price collapses have 12–18 month precedents. Conversely, MSFT’s share-price weakness may underprice durable monopoly economics in enterprise AI (agents, security) meaning patient buyers could capture >2x upside over 3–5 years if revenue mix shifts to high‑margin AI services.